Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents
Abstract
Background Methylphenidate (MP) and amphetamine, which are the mainstay for the treatment of ADHD, have raised concerns because of their reinforcing effects and the fear that their chronic use during childhood or adolescence could induce changes in the brain that could facilitate drug abuse in adulthood.Methods Here we measured the effects of chronic treatment (8 months) with oral MP (1 or 2 mg/kg), which was initiated in periadolescent rats (postnatal day 30). Following this treatment, rats were tested on cocaine self-administration. In addition at 2 and 8 months of treatment we measured dopamine D2 receptor (D2R) availability in the striatum using [(11)C]raclopride microPET (microPET) imaging.Results Animals treated for 8 months with 2 mg/kg of MP showed significantly reduced rates of cocaine self-administration at adulthood than vehicle treated rats. D2R availability in the striatum was significantly lower in rats after 2 months of treatment with MP (1 and 2 mg/kg) but significantly higher after 8 months of MP treatment than in the vehicle treated rats. In vehicle treated rats D2R availability decreased with age whereas it increased in rats treated with MP. Because low D2R levels in the striatum are associated with a propensity for self-administration of drugs both in laboratory animals and in humans, this effect could underlie the lower rates of cocaine self-administration observed in the rats given 8 months of treatment with MP.Conclusions Eight month treatment with oral MP beginning in adolescence decreased cocaine-self administration (1 mg/kg) during adulthood which could reflect the increases in D2R availability observed at this life stage since D2R increases are associated with reduced propensity for cocaine self administration. In contrast, two month treatment with MP started also at adolescence decreased D2R availability, which could raise concern that at this life stage short treatments could possibly increase vulnerability to drug abuse during adulthood. These findings indicate that MP effects on D2R expression in the striatum are sensitive not only to length of treatment but also to the developmental stage at which treatment is given. Future studies evaluating the effects of different lengths of treatment on drug self-administration are required to assess optimal duration of treatment regimes to minimize adverse effects on the propensity for drug self administration.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Repeated drug exposures in rodents and non-human primates are associated with reductions in striatal D2R levels and D2R signalling.
“preclinical studies in rodent and non-human primates have shown that repeated drug exposures are associated with reductions in striatal D2R levels and in D2R signalling (65–67).”
From Obesity and addiction: Neurobiological overlaps (2013) · cites this paper as [65]
Preclinical studies in rodent and non-human primates have shown that repeated drug exposures are associated with reductions in striatal D2R levels.
“Similarly, preclinical studies in rodent and non-human primates have shown that repeated drug exposures are associated with reductions in striatal D2R levels (Nader et al 2006;Thanos et al 2007;Volkow et al 2001).”
From Food and Drug Reward: Overlapping Circuits in Human Obesity and Addiction (2011) · cites this paper as Thanos et al 2007
The citation lists haven’t been fetched yet
References 57 · Cited by 100
- Authors
- Thanos, P. K., Michaelides, M., Benveniste, H., Wang, G. J., & Volkow, N. D.
- Affiliations
- National Institutes of Health (US)
- Brookhaven National Laboratory (US)
- Corresponding author
- Thanos, Panayotis K.
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 87
- Issue
- 4
- Pages
- 426-433
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W2145191694
- Cited by
- 100
- References
- 57
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 9 · 2014: 6 · 2013: 8 · 2012: 7
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacology Biochemistry and Behavior (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Energy
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- methylphenidate, cocaine self-administration, dopamine D2 receptor, striatum, chronic drug administration, adolescence, ADHD medication, drug abuse vulnerability, receptor availability
- MeSH terms
- Central Nervous System Stimulants, Animals, Body Weight, Cocaine, Magnetic Resonance Imaging, Male, Methylphenidate, Self Administration, Neostriatum, Rats, Sprague-Dawley, Receptors, Dopamine D2, Dopamine Antagonists, Dopamine Uptake Inhibitors, Cocaine-Related Disorders, Raclopride, Positron-Emission Tomography, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review